187 related articles for article (PubMed ID: 16960300)
1. Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage.
Wang H; Gao J; Lassiter TF; McDonagh DL; Sheng H; Warner DS; Lynch JR; Laskowitz DT
Neurocrit Care; 2006; 5(1):71-8. PubMed ID: 16960300
[TBL] [Abstract][Full Text] [Related]
2. A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage.
Gao J; Wang H; Sheng H; Lynch JR; Warner DS; Durham L; Vitek MP; Laskowitz DT
Neurocrit Care; 2006; 4(1):25-31. PubMed ID: 16498192
[TBL] [Abstract][Full Text] [Related]
3. Antiepileptic drugs in aneurysmal subarachnoid hemorrhage.
Zubkov AY; Wijdicks EF
Rev Neurol Dis; 2008; 5(4):178-81. PubMed ID: 19122570
[TBL] [Abstract][Full Text] [Related]
4. Incidence of delayed seizures, delayed cerebral ischemia and poor outcome with the use of levetiracetam versus phenytoin after aneurysmal subarachnoid hemorrhage.
Karamchandani RR; Fletcher JJ; Pandey AS; Rajajee V
J Clin Neurosci; 2014 Sep; 21(9):1507-13. PubMed ID: 24919470
[TBL] [Abstract][Full Text] [Related]
5. Abbreviated levetiracetam treatment effects on behavioural and histological outcomes after experimental TBI.
Zou H; Hurwitz M; Fowler L; Wagner AK
Brain Inj; 2015; 29(1):78-85. PubMed ID: 25255156
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E mimetic peptide CN-105 improves outcome in a murine model of SAH.
Liu J; Zhou G; Kolls BJ; Tan Y; Fang C; Wang H; Laskowitz DT
Stroke Vasc Neurol; 2018 Dec; 3(4):222-230. PubMed ID: 30637128
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent effects of levetiracetam after hypoxia and hypothermia in the neonatal mouse brain.
Strasser K; Lueckemann L; Kluever V; Thavaneetharajah S; Hoeber D; Bendix I; Fandrey J; Bertsche A; Felderhoff-Mueser U
Brain Res; 2016 Sep; 1646():116-124. PubMed ID: 27216570
[TBL] [Abstract][Full Text] [Related]
8. Protective action of NDP-MSH in experimental subarachnoid hemorrhage.
Gatti S; Lonati C; Acerbi F; Sordi A; Leonardi P; Carlin A; Gaini SM; Catania A
Exp Neurol; 2012 Mar; 234(1):230-8. PubMed ID: 22230666
[TBL] [Abstract][Full Text] [Related]
9. Initial EEG predicts outcomes in a trial of levetiracetam vs. fosphenytoin for seizure prevention.
Steinbaugh LA; Lindsell CJ; Shutter LA; Szaflarski JP
Epilepsy Behav; 2012 Mar; 23(3):280-4. PubMed ID: 22342434
[TBL] [Abstract][Full Text] [Related]
10. Comparison of short-duration levetiracetam with extended-course phenytoin for seizure prophylaxis after subarachnoid hemorrhage.
Murphy-Human T; Welch E; Zipfel G; Diringer MN; Dhar R
World Neurosurg; 2011 Feb; 75(2):269-74. PubMed ID: 21492729
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America.
Haley EC; Kassell NF; Apperson-Hansen C; Maile MH; Alves WM
J Neurosurg; 1997 Mar; 86(3):467-74. PubMed ID: 9046304
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm.
Lin CL; Dumont AS; Calisaneller T; Kwan AL; Hwong SL; Lee KS
Surg Neurol; 2005 Sep; 64(3):201-5; discussion 205-6. PubMed ID: 16099244
[TBL] [Abstract][Full Text] [Related]
13. Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients.
Spencer DD; Jacobi J; Juenke JM; Fleck JD; Kays MB
Pharmacotherapy; 2011 Oct; 31(10):934-41. PubMed ID: 21950640
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of curcumin in an experimental rat model of subarachnoid hemorrhage.
Kuo CP; Lu CH; Wen LL; Cherng CH; Wong CS; Borel CO; Ju DT; Chen CM; Wu CT
Anesthesiology; 2011 Dec; 115(6):1229-38. PubMed ID: 21926905
[TBL] [Abstract][Full Text] [Related]
15. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to L-arginine infusion after subarachnoid hemorrhage.
Pluta RM; Afshar JK; Thompson BG; Boock RJ; Harvey-White J; Oldfield EH
J Neurosurg; 2000 Jan; 92(1):121-6. PubMed ID: 10616090
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM
J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245
[TBL] [Abstract][Full Text] [Related]
17. Systemic L-citrulline prevents cerebral vasospasm in haptoglobin 2-2 transgenic mice after subarachnoid hemorrhage.
Pradilla G; Garzon-Muvdi T; Ruzevick JJ; Bender M; Edwards L; Momin EN; Thompson RC; Tamargo RJ
Neurosurgery; 2012 Mar; 70(3):747-56; discussion 756-7. PubMed ID: 21915076
[TBL] [Abstract][Full Text] [Related]
18. Low-dose lipopolysaccharide injection prior to subarachnoid hemorrhage modulates Delayed Deterioration associated with vasospasm in subarachnoid hemorrhage.
Smithason S; Moore SK; Provencio JJ
Acta Neurochir Suppl; 2013; 115():253-8. PubMed ID: 22890677
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of hydrogen-rich saline on cerebral vasospasm after experimental subarachnoid hemorrhage in rats.
Hong Y; Guo S; Chen S; Sun C; Zhang J; Sun X
J Neurosci Res; 2012 Aug; 90(8):1670-80. PubMed ID: 22589232
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective, neuroplastic, and neurobehavioral effects of daily treatment with levetiracetam in experimental traumatic brain injury.
Zou H; Brayer SW; Hurwitz M; Niyonkuru C; Fowler LE; Wagner AK
Neurorehabil Neural Repair; 2013; 27(9):878-88. PubMed ID: 23812605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
